Shari I. Lusskin
- SENIOR FACULTY Psychiatry
Psychiatry, American Board of Psychiatry and Neurology
MD, NYU Medical Center
B.A., Williams College
New York University School of Medicine
Research interests include:Postpartum Depression
Lusskin S, Misri S. Treatment of Psychiatric Disorders in Pregnancy. In: Rose BD, editor. UpToDate (2008). Wellesley, MA,.
Lusskin S, Misri S. Bipolar Disorder, Schizophrenia, and Psychotic Depression in Pregnant and Postpartum Women. In: Rose BD, editor. UpToDate (2008). Wellesley, MA,.
Rose BD, Misri S, Lusskin S. Use of Psychotropic Medications in Breastfeeding Women. In: UpToDate (2008). Wellesley, MA,.
Lusskin SI, Turco J. Should You Give a Pregnant Woman SSRIs? (http://www.contemporaryobgyn.net/). Contemporary Ob/Gyn 2008 February 1;.
Cutler CB, Legano LA, Dreyer BP, Fierman AH, Berkule SB, Lusskin SI, Tomopoulos S, Roth M, Mendelsohn AL. Screening for maternal depression in a low education population using a two item questionnaire [Epub ahead of print]. Arch Womens Ment Health 2007 Aug 22;.
Lusskin S, Pundiak T, Habib S. Perinatal Depression: Hiding in Plain Sight. Can Journal of Psychiatry 2007; 52(8): 479-488.
Lee MJ, Roman AS, Lusskin S, Chen D, Dulay A, Funai EF, Monteagudo A. Maternal anxiety and ultrasound markers for aneuploidy in a multiethnic population. Prenatal Diagnosis 2007; 27(1): 40-45.
Golub M, Costa L, Crofton K, Frank D, Fried P, Gladen B, Henderson R, Liebelt E, Lusskin S, Marty S, Rowland A, Scialli J, Vore M. NTP-CERHR expert panel report on the reproductive and developmental toxicity of methylphenidate. Birth defects research. Pt B.. Developmental & reproductive toxicology 2005; 74: 300-381.
Golub M, Costa L, Crofton K, Frank D, Fried P, Gladen B, Henderson R, Liebelt E, Lusskin S, Marty S, Rowland A, Scialli J, Vore M. NTP-CERHR expert panel report on the reproductive and developmental toxicity of amphetamine and methamphetamine. Birth defects research. Pt B. . Developmental & reproductive toxicology 2005; 74: 471-584.
Lusskin SI, Cancro RC, Chuang L, Jacobson J. Prolactin Elevation with Ziprasidone, letter to the editor. American Journal of Psychiatry 2004; 161(10): 1925.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Lusskin is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
161 Madison Avenue
New York, NY 10016